These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1257 related articles for article (PubMed ID: 23181712)

  • 1. Cardiovascular risk of essential hypertension: influence of class, number, and treatment-time regimen of hypertension medications.
    Hermida RC; Ayala DE; Mojón A; Fernández JR
    Chronobiol Int; 2013 Mar; 30(1-2):315-27. PubMed ID: 23181712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of time-of-day of hypertension treatment on the J-shaped relationship between blood pressure and cardiovascular risk.
    Hermida RC; Ayala DE; Mojón A; Fernández JR
    Chronobiol Int; 2013 Mar; 30(1-2):328-39. PubMed ID: 23181738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blunted sleep-time relative blood pressure decline increases cardiovascular risk independent of blood pressure level--the "normotensive non-dipper" paradox.
    Hermida RC; Ayala DE; Mojón A; Fernández JR
    Chronobiol Int; 2013 Mar; 30(1-2):87-98. PubMed ID: 23039824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular risk of resistant hypertension: dependence on treatment-time regimen of blood pressure-lowering medications.
    Ayala DE; Hermida RC; Mojón A; Fernández JR
    Chronobiol Int; 2013 Mar; 30(1-2):340-52. PubMed ID: 23077973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of circadian time of hypertension treatment on cardiovascular risk: results of the MAPEC study.
    Hermida RC; Ayala DE; Mojón A; Fernández JR
    Chronobiol Int; 2010 Sep; 27(8):1629-51. PubMed ID: 20854139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of time-of-day of hypertension treatment on ambulatory blood pressure and clinical characteristics of patients with type 2 diabetes.
    Moyá A; Crespo JJ; Ayala DE; Ríos MT; Pousa L; Callejas PA; Salgado JL; Mojón A; Fernández JR; Hermida RC;
    Chronobiol Int; 2013 Mar; 30(1-2):116-31. PubMed ID: 23181613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Administration-time-dependent effects of hypertension treatment on ambulatory blood pressure in patients with chronic kidney disease.
    Crespo JJ; Piñeiro L; Otero A; Castiñeira C; Ríos MT; Regueiro A; Mojón A; Lorenzo S; Ayala DE; Hermida RC;
    Chronobiol Int; 2013 Mar; 30(1-2):159-75. PubMed ID: 23098134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment-time regimen of hypertension medications significantly affects ambulatory blood pressure and clinical characteristics of patients with resistant hypertension.
    Hermida RC; Ríos MT; Crespo JJ; Moyá A; Domínguez-Sardiña M; Otero A; Sánchez JJ; Mojón A; Fernández JR; Ayala DE;
    Chronobiol Int; 2013 Mar; 30(1-2):192-206. PubMed ID: 23098160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sleep-time blood pressure: prognostic value and relevance as a therapeutic target for cardiovascular risk reduction.
    Hermida RC; Ayala DE; Fernández JR; Mojón A
    Chronobiol Int; 2013 Mar; 30(1-2):68-86. PubMed ID: 23181592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of age and hypertension treatment-time on ambulatory blood pressure in hypertensive patients.
    Hermida RC; Ayala DE; Crespo JJ; Mojón A; Chayán L; Fontao MJ; Fernández JR
    Chronobiol Int; 2013 Mar; 30(1-2):176-91. PubMed ID: 23077974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences between men and women in ambulatory blood pressure thresholds for diagnosis of hypertension based on cardiovascular outcomes.
    Hermida RC; Ayala DE; Mojón A; Fontao MJ; Chayán L; Fernández JR
    Chronobiol Int; 2013 Mar; 30(1-2):221-32. PubMed ID: 23098170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ambulatory blood pressure monitoring: importance of sampling rate and duration--48 versus 24 hours--on the accurate assessment of cardiovascular risk.
    Hermida RC; Ayala DE; Fontao MJ; Mojón A; Fernández JR
    Chronobiol Int; 2013 Mar; 30(1-2):55-67. PubMed ID: 23077972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronotherapy with valsartan/hydrochlorothiazide combination in essential hypertension: improved sleep-time blood pressure control with bedtime dosing.
    Hermida RC; Ayala DE; Mojón A; Fontao MJ; Fernández JR
    Chronobiol Int; 2011 Aug; 28(7):601-10. PubMed ID: 21823969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ambulatory blood pressure thresholds for diagnosis of hypertension in patients with and without type 2 diabetes based on cardiovascular outcomes.
    Hermida RC; Ayala DE; Mojón A; Fernández JR
    Chronobiol Int; 2013 Mar; 30(1-2):132-44. PubMed ID: 23181634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sleep-time blood pressure as a therapeutic target for cardiovascular risk reduction in type 2 diabetes.
    Hermida RC; Ayala DE; Mojón A; Fernández JR
    Am J Hypertens; 2012 Mar; 25(3):325-34. PubMed ID: 22158066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronotherapy with valsartan/amlodipine fixed combination: improved blood pressure control of essential hypertension with bedtime dosing.
    Hermida RC; Ayala DE; Fontao MJ; Mojón A; Fernández JR
    Chronobiol Int; 2010 Jul; 27(6):1287-303. PubMed ID: 20653455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ambulatory blood pressure monitoring in the prediction of cardiovascular events and effects of chronotherapy: rationale and design of the MAPEC study.
    Hermida RC
    Chronobiol Int; 2007; 24(4):749-75. PubMed ID: 17701685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Administration-time differences in effects of hypertension medications on ambulatory blood pressure regulation.
    Hermida RC; Ayala DE; Fernández JR; Mojón A; Smolensky MH; Fabbian F; Portaluppi F
    Chronobiol Int; 2013 Mar; 30(1-2):280-314. PubMed ID: 23077971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circadian pattern of ambulatory blood pressure in hypertensive patients with and without type 2 diabetes.
    Ayala DE; Moyá A; Crespo JJ; Castiñeira C; Domínguez-Sardiña M; Gomara S; Sineiro E; Mojón A; Fontao MJ; Hermida RC;
    Chronobiol Int; 2013 Mar; 30(1-2):99-115. PubMed ID: 23098178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and clinical characteristics of isolated-office and true resistant hypertension determined by ambulatory blood pressure monitoring.
    Ríos MT; Domínguez-Sardiña M; Ayala DE; Gomara S; Sineiro E; Pousa L; Callejas PA; Fontao MJ; Fernández JR; Hermida RC;
    Chronobiol Int; 2013 Mar; 30(1-2):207-20. PubMed ID: 23077975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 63.